China

2

Review clinical trials related to China. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

Acetaminophen (APAP) is the most commonly used NSAIDS in clinic, and it is also a common cause of drug-induced liver injury (DILI). In 2012, the proportion of DILI caused by APAP in the United States was 51%, while in Asia, it was only 7.10%. Previously, a small cohort study in the United States screened for some of the susceptibility genes for DILI due to APAP by the Genome wide association study (GWAS) method. However, the genetic susceptibility loci based on the US cohort were not applicable to the Chinese population. Therefore, we make a study design include Chinese population who ingested APAP and divided them into case group and control group according to the occurrence of DILI. We hope to be able to find the root of differences at the genetic level and explore new pathogenic mechanisms.

Participants needed: 339
Trial details
Age: 14+Biological sex: AllType: ObservationalSponsor: The First Affiliated Hospital with Nanjing Medical UniversityUpdated: Feb 26, 2025Locations: 1
Eligibility criteria

A clear history of acetaminophen (or acetaminophen-containing drugs) ingestion. [+4]

The use of drugs for which frequency of adverse reactions to liver damage is def... [+4]

Status: Recruiting

Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.

Participants needed: 300
Trial details
Biological sex: FemaleType: ObservationalSponsor: Fujian Maternity and Child Health HospitalUpdated: Sep 19, 2024Locations: 9
Eligibility criteria

Patients diagnosed with cervical neuroendocrine carcinoma by histopathology [+1]

Patients who are not being treated in our hospital [+3]